AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Nobeglar-Uno Injection

Prescription Icon
Prescription Required

Marketer

Mankind Pharma Ltd

Salt Composition

Insulin Glargine (100IU)

Overview Nobeglar-Uno Injection

InsuLinR-One is a prolonged-release insulin formulation indicated for managing type 1 and type 2 diabetes in adults and pediatric patients. Offering consistent daily insulin levels, it effectively regulates blood glucose, mitigating diabetes-related complications. InsuLinR-One may be administered solely or in conjunction with rapid-acting insulin or other antidiabetic agents. Proper subcutaneous injection technique will be demonstrated by your healthcare provider. Adherence to the prescribed dosage is crucial for optimal therapeutic effects; discontinuation may result in dangerously elevated blood sugar and severe complications. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your physician. Hypoglycemia (low blood sugar) is a frequent adverse effect; precise dosing, regular meals, and consistent blood glucose monitoring are vital for prevention. Excessive alcohol consumption can also precipitate hypoglycemia. Additional potential side effects include peripheral swelling, fat tissue changes at the injection site, allergic reactions, injection site reactions, itching, skin rashes, and weight increase. Avoid use during episodes of hypoglycemia. Prior to commencing treatment, disclose any history of kidney, liver, or heart disease to your doctor. Consult your physician before using InsuLinR-One if you are pregnant or breastfeeding.

Primary Ingredients of Nobeglar-Uno Injection

The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.

Uses of Nobeglar-Uno Injection

High blood sugar condition

Major Benefits of Nobeglar-Uno Injection:

The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Nobeglar-Uno Injection:

  • Hypoglycemia (low blood glucose level)
  • Peripheral edema
  • Lipodystrophy (skin thickening or pits at the injection site)
  • Allergic reaction
  • Injection site reactions (pain, swelling, redness)
  • Itching
  • Rash
  • Weight gain

How to use Nobeglar-Uno Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.

How Nobeglar-Uno Injection works:

Nobeglar-Uno Injection, a sustained-release insulin formulation, offers consistent blood glucose management throughout the day. Its action mimics the body's natural insulin function, promoting glucose absorption into muscle and fat tissues while simultaneously inhibiting hepatic glucose production.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Nobeglar-Uno Injection should not be used concurrently with alcohol consumption.

PregnancyPregnancySAFE IF PRESCRIBED

The injectable medication Nobeglar-Uno is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The administration of Nobeglar-Uno Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Nobeglar-Uno Injection to individuals with impaired renal function. Dosage modifications for Nobeglar-Uno Injection may be necessary. Physician consultation is advised. Routine monitoring of blood glucose is recommended to guide dosage adjustments.

LiverLiverCAUTION

Patients with hepatic impairment should receive Nobeglar-Uno Injection with careful consideration. Dosage modification of Nobeglar-Uno Injection may be necessary. Physician consultation is advised. Routine monitoring of blood glucose is suggested to guide dosage adjustments.

What if you forget to take Nobeglar-Uno Injection :

Should you forget a Nobeglar-Uno Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Nobeglar-Uno Injection

LabelValue
Chemical Category Modified insulin
Developing Habits No.
Type of Therapy Diabetes Management
Behavior Class Long-acting insulin analogs

FAQs on Nobeglar-Uno Injection

Nobeglar-Uno Injection is a synthetic insulin closely resembling human insulin. Its prolonged, consistent action regulates blood sugar levels for 24 hours, allowing for once-daily administration. It's indicated for treating type 1 and type 2 diabetes mellitus in adults, and type 1 diabetes in children.
Nobeglar-Uno Injection is administered subcutaneously. Your doctor will instruct you on the proper injection technique and suitable sites (abdomen, thighs, arms, hips, or buttocks). Rotate injection sites within the chosen area, spacing injections approximately 1cm apart to prevent complications. Alternate injection sides daily. After one to two weeks, change injection areas as directed by your doctor. Consult your doctor immediately if you experience any difficulties.
Nobeglar-Uno Injection is a once-daily, long-acting medication. While it can be administered at any time, consistent daily timing is recommended.
Accidental overdose of Nobeglar-Uno Injection can cause dangerously low blood sugar (hypoglycemia), ranging from mild to severe. Closely monitor your blood sugar levels for 24 hours. Mild hypoglycemia, with symptoms like anxiety, sweating, weakness, tremors, or rapid heartbeat, often responds to sugary foods (candy, fruit juice, glucose). However, always consult your doctor for further guidance. Severe hypoglycemia may cause seizures or unconsciousness, requiring immediate emergency medical attention.
Store Nobeglar-Uno Injection, in its original container, out of children's reach. Unopened vials and pens should be refrigerated, but not frozen. Refrigerate unopened injections until the expiration date on the label. Discard any injection that has been frozen or thawed. If refrigeration isn't possible, store unopened vials at room temperature, protected from direct sunlight and heat. The solution should be clear, colorless, and particle-free.
Discuss insulin dose adjustments with your doctor. Closely monitor blood sugar if unwell. Inform your doctor of all medications you're taking, as they can interact with insulin and require dose changes. Changes in eating habits (e.g., missed meals, increased or decreased food intake) also affect insulin needs. Blood sugar levels can fluctuate due to exercise, alcohol, or stress. Pregnant or breastfeeding individuals should consult their doctor before using Nobeglar-Uno Injection, as dose adjustments may be necessary.
Nobeglar-Uno Injection rarely causes serious side effects. However, severe allergic reactions, including rash, hives, itching, difficulty breathing, rapid heart rate, and low blood pressure, are possible. Seek immediate medical attention if these occur. Other potential side effects include severe hypoglycemia (low blood sugar), manifesting as dizziness, sweating, anxiety, confusion, headache, blurred vision, slurred speech, shakiness, rapid heartbeat, seizures, or unconsciousness. Concurrent use of TZDs (thiazolidinediones) may increase the risk of heart failure, even in those without prior heart conditions. Sudden weight gain and ankle/foot swelling are also possible. Report any of these side effects to your doctor immediately.
Nobeglar-Uno Injection
646
MRP 749
13% off